Advancement in Cancer Vasculogenesis Modeling Through 3D Bioprinting Technology

Overview

Journal Biomimetics (Basel)

Date 2024 May 24

PMID 38786516

Authors

Arvind Kumar Shukla

Sik Yoon

Sae-Ock Oh

Dongjun Lee

Minjun Ahn

Byoung Soo Kim

Affiliations

Soon will be listed here.

Abstract

Cancer vasculogenesis is a pivotal focus of cancer research and treatment given its critical role in tumor development, metastasis, and the formation of vasculogenic microenvironments. Traditional approaches to investigating cancer vasculogenesis face significant challenges in accurately modeling intricate microenvironments. Recent advancements in three-dimensional (3D) bioprinting technology present promising solutions to these challenges. This review provides an overview of cancer vasculogenesis and underscores the importance of precise modeling. It juxtaposes traditional techniques with 3D bioprinting technologies, elucidating the advantages of the latter in developing cancer vasculogenesis models. Furthermore, it explores applications in pathological investigations, preclinical medication screening for personalized treatment and cancer diagnostics, and envisages future prospects for 3D bioprinted cancer vasculogenesis models. Despite notable advancements, current 3D bioprinting techniques for cancer vasculogenesis modeling have several limitations. Nonetheless, by overcoming these challenges and with technological advances, 3D bioprinting exhibits immense potential for revolutionizing the understanding of cancer vasculogenesis and augmenting treatment modalities.

References

Popel A . Theory of oxygen transport to tissue. Crit Rev Biomed Eng. 1989; 17(3):257-321. PMC: 5445261. View

Sharma R, Restan Perez M, da Silva V, Thomsen J, Bhardwaj L, Andrade T . 3D bioprinting complex models of cancer. Biomater Sci. 2023; 11(10):3414-3430. DOI: 10.1039/d2bm02060b. View

Flores-Torres S, Dimitriou N, Pardo L, Kort-Mascort J, Pal S, Peza-Chavez O . Bioprinted Multicomponent Hydrogel Co-culture Tumor-Immune Model for Assessing and Simulating Tumor-Infiltrated Lymphocyte Migration and Functional Activation. ACS Appl Mater Interfaces. 2023; 15(28):33250-33262. DOI: 10.1021/acsami.3c02995. View

Wang Z, Abdulla R, Parker B, Samanipour R, Ghosh S, Kim K . A simple and high-resolution stereolithography-based 3D bioprinting system using visible light crosslinkable bioinks. Biofabrication. 2015; 7(4):045009. DOI: 10.1088/1758-5090/7/4/045009. View

Ze Y, Li Y, Huang L, Shi Y, Li P, Gong P . Biodegradable Inks in Indirect Three-Dimensional Bioprinting for Tissue Vascularization. Front Bioeng Biotechnol. 2022; 10:856398. PMC: 8990266. DOI: 10.3389/fbioe.2022.856398. View

Wang X, Luo Y, Ma Y, Wang P, Yao R . Converging bioprinting and organoids to better recapitulate the tumor microenvironment. Trends Biotechnol. 2023; 42(5):648-663. DOI: 10.1016/j.tibtech.2023.11.006. View

Deng C, Zhao J, Zhou S, Dong J, Cao J, Gao J . The Vascular Disrupting Agent CA4P Improves the Antitumor Efficacy of CAR-T Cells in Preclinical Models of Solid Human Tumors. Mol Ther. 2019; 28(1):75-88. PMC: 6953963. DOI: 10.1016/j.ymthe.2019.10.010. View

Teleanu R, Chircov C, Grumezescu A, Teleanu D . Tumor Angiogenesis and Anti-Angiogenic Strategies for Cancer Treatment. J Clin Med. 2020; 9(1). PMC: 7020037. DOI: 10.3390/jcm9010084. View

Roy V, Magne B, Vaillancourt-Audet M, Blais M, Chabaud S, Grammond E . Human Organ-Specific 3D Cancer Models Produced by the Stromal Self-Assembly Method of Tissue Engineering for the Study of Solid Tumors. Biomed Res Int. 2020; 2020:6051210. PMC: 7178531. DOI: 10.1155/2020/6051210. View

10.

Yu R, Maswikiti E, Yu Y, Gao L, Ma C, Ma H . Advances in the Application of Preclinical Models in Photodynamic Therapy for Tumor: A Narrative Review. Pharmaceutics. 2023; 15(1). PMC: 9867105. DOI: 10.3390/pharmaceutics15010197. View

11.

Subramanian A, Zakeri P, Mousa M, Alnaqbi H, Alshamsi F, Bettoni L . Angiogenesis goes computational - The future way forward to discover new angiogenic targets?. Comput Struct Biotechnol J. 2022; 20:5235-5255. PMC: 9508490. DOI: 10.1016/j.csbj.2022.09.019. View

12.

Molander D, Sbirkov Y, Sarafian V . 3D bioprinting as an emerging standard for cancer modeling and drug testing. Folia Med (Plovdiv). 2022; 64(4):559-565. DOI: 10.3897/folmed.64.e73419. View

13.

Jubelin C, Munoz-Garcia J, Griscom L, Cochonneau D, Ollivier E, Heymann M . Three-dimensional in vitro culture models in oncology research. Cell Biosci. 2022; 12(1):155. PMC: 9465969. DOI: 10.1186/s13578-022-00887-3. View

14.

Ahn M, Cho W, Lee H, Park W, Lee S, Back J . Engineering of Uniform Epidermal Layers via Sacrificial Gelatin Bioink-Assisted 3D Extrusion Bioprinting of Skin. Adv Healthc Mater. 2023; 12(27):e2301015. DOI: 10.1002/adhm.202301015. View

15.

Kong Z, Wang X . Bioprinting Technologies and Bioinks for Vascular Model Establishment. Int J Mol Sci. 2023; 24(1). PMC: 9821327. DOI: 10.3390/ijms24010891. View

16.

Holzl K, Lin S, Tytgat L, Van Vlierberghe S, Gu L, Ovsianikov A . Bioink properties before, during and after 3D bioprinting. Biofabrication. 2016; 8(3):032002. DOI: 10.1088/1758-5090/8/3/032002. View

17.

Monahan-Earley R, Dvorak A, Aird W . Evolutionary origins of the blood vascular system and endothelium. J Thromb Haemost. 2013; 11 Suppl 1:46-66. PMC: 5378490. DOI: 10.1111/jth.12253. View

18.

Vitale C, Marzagalli M, Scaglione S, Dondero A, Bottino C, Castriconi R . Tumor Microenvironment and Hydrogel-Based 3D Cancer Models for In Vitro Testing Immunotherapies. Cancers (Basel). 2022; 14(4). PMC: 8870468. DOI: 10.3390/cancers14041013. View

19.

Yeo M, Sarkar A, Singh Y, Derman I, Datta P, Ozbolat I . Synergistic coupling between 3D bioprinting and vascularization strategies. Biofabrication. 2023; 16(1). PMC: 10658349. DOI: 10.1088/1758-5090/ad0b3f. View

20.

Fedi A, Vitale C, Ponschin G, Ayehunie S, Fato M, Scaglione S . In vitro models replicating the human intestinal epithelium for absorption and metabolism studies: A systematic review. J Control Release. 2021; 335:247-268. DOI: 10.1016/j.jconrel.2021.05.028. View